P. Clavère

Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study

Jean-François Bosset, G. Calais, Laurent Mineur et al. · The Lancet Oncology · 2014 · 718 citations

Surgical Oncology, Fluorouracil-based Adjuvant Chemotherapy, Eortc 22921 +9

Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions

J. J. Bonerandi, Céline Beauvillain, L. Caquant et al. · Journal of the European Academy of Dermatology and Venereology · 2011 · 166 citations · Full text

Randomized Trial Comparing Six Versus Three Cycles of Epirubicin-Based Adjuvant Chemotherapy in Premenopausal, Node-Positive Breast Cancer Patients: 10-Year Follow-Up Results of the French Adjuvant Study Group 01 Trial

P. Fumoleau, Pierre Kerbrat, P. Romestaing et al. · Journal of Clinical Oncology · 2003 · 106 citations

Long-Term Cardiac Follow-Up in Relapse-Free Patients After Six Courses of Fluorouracil, Epirubicin, and Cyclophosphamide, With Either 50 or 100 mg of Epirubicin, As Adjuvant Therapy for Node-Positive Breast Cancer: French Adjuvant Study Group

Jacques Bonneterre, Henri Roché, Pierre Kerbrat et al. · Journal of Clinical Oncology · 2004 · 99 citations · Full text

Heart Failure, Breast Oncology, Cardiac Risk Factors +19

Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: Results of the French M-SFOP 98 protocol

C. Carrié, Xavier Muracciole, Frédéríc Gomez et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 95 citations

Neuro-oncology, Surgical Oncology, Online Quality Control +9